Watershed Informatics
Powering insights across the life sciences
Cambridge, United States · Founded 2021 · $184.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- watershedinformatics.com
- Total Funding
- $184.5M
- Last Round
- $100.0M Series CFeb 2024
- Rounds
- 4
About
Watershed (formerly Watershed Informatics) is a cloud platform for biological data analysis, discovery, and collaboration purpose-built for the life sciences. The platform enables researchers to securely access, manage, and harmonize complex multi-omics datasets — including genomics, transcriptomics, proteomics, and epigenomics — run analyses using customizable workflows with ready-to-use AI tools, and leverage supercomputing infrastructure to complete large-scale analyses in minutes instead of weeks. Watershed processes over 300TB of biological data per month and serves customers at Harvard Medical School, MIT, MGH, UCSD, Stanford, Northwestern, and multiple biopharma companies. The platform upholdes FAIR data principles and provides access to both public and controlled-access datasets.
Summary
Watershed Informatics is a Bioinformatics company based in Cambridge, United States, founded in 2021. It has raised $184.5M in total across 4 rounds, most recently a $100.0M Series C round in Feb 2024. Investors include Kleiner Perkins, Sequoia Capital and Greenoaks Capital.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.

